Selfcare MAnagement InteRvenTion in Heart Failure II (SMART HF II)
NCT ID: NCT04327128
Last Updated: 2021-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2019-05-29
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate whether a digital support and communication platform for heart failure patients after 6 months can provide:
1. Improved self-care
2. Improved quality of life and reduced number of patient-assessed symptoms
3. Reduction in the number of cardiovascular events, hospital nights, the number of hospitalizations or the number of deaths and out-patient visits
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Selfcare Management Intervention in Heart Failure
NCT03484286
A Digital Solution for Patients With Heart Failure
NCT05193344
Self-Management and Care of Heart Failure With Group Clinics (SMAC-HF)
NCT00439842
Mobile App for Heart Failure
NCT05668000
Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure
NCT01216670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Standard heart failure care and a digital heart failure support system
LifePod
The intervention group is testing LifePod on a digital communication platform between patient and healthcare provider
Control group
Standard heart failure care
LifePod
The intervention group is testing LifePod on a digital communication platform between patient and healthcare provider
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LifePod
The intervention group is testing LifePod on a digital communication platform between patient and healthcare provider
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient who declines to participate in the trial.
* Impaired cognitive ability that is judged to affect the ability to conduct the study in the intended manner.
* Life expectancy \<8 months
* In other ways, by the treating physician, it is deemed inappropriate to participate in the study, e.g. due to participation in another study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sofia Gerward
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sofia Gerward, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Lund University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lund University
Lund, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMART HF II, Dnr 20 19-00378
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.